Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PROF | CRBP | GALT | ||
| Company | Profound Medical Corp | Corbus Pharmaceuticals Hldgs Inc | Galectin Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.90 | 20.07 | 2.75 | ||
| High | 8.01 | 20.34 | 3.16 | ||
| Low | 7.82 | 18.89 | 2.73 | ||
| Last | 7.82 | 19.21 | 2.82 | ||
| Change | -0.10 | -0.70 | +0.10 | ||
| % Change | -1.26% | -3.52% | +3.68% | ||
| Volume | 45,700 | 485,100 | 408,300 | ||
| 20-Day Average Volume | 74,105 | 1,357,020 | 133,485 | ||
| Previous Close | 7.92 | 19.91 | 2.72 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.81 | 34.73 | 2.72 | ||
| 20-Day Raw Stochastic | 37.44% | 5.53% | 55.20% | ||
| 20-Day Relative Strength | 42.46% | 29.98% | 57.69% | ||
| Weighted Alpha | -20.45 | +35.56 | +4.93 | ||
| Today's Opinion | 24% Sell | 56% Sell | 72% Buy | ||
| Previous Opinion | 24% Sell | 56% Sell | 72% Buy | ||
| Last Month's Opinion | 24% Sell | 64% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.26% since 09/27/24 | -8.17% since 09/27/24 | +4.06% since 09/27/24 | ||
| Low | 7.82 on 10/04/24 | 18.83 on 10/01/24 | 2.67 on 10/01/24 | ||
| High | 8.48 on 10/02/24 | 21.85 on 09/30/24 | 3.16 on 10/04/24 | ||
| 1-Month | |||||
| %Chg | -8.00% since 09/04/24 | -65.31% since 09/04/24 | +15.10% since 09/04/24 | ||
| Low | 7.43 on 09/25/24 | 17.00 on 09/20/24 | 2.40 on 09/06/24 | ||
| High | 8.69 on 09/05/24 | 56.93 on 09/16/24 | 3.16 on 10/04/24 | ||
| 3-Month | |||||
| %Chg | -9.70% since 07/03/24 | -61.32% since 07/03/24 | +31.16% since 07/03/24 | ||
| Low | 7.43 on 09/25/24 | 17.00 on 09/20/24 | 1.98 on 08/12/24 | ||
| High | 11.42 on 07/26/24 | 61.90 on 07/31/24 | 3.16 on 10/04/24 | ||
| 6-Month | |||||
| %Chg | -4.75% since 04/04/24 | -50.71% since 04/04/24 | -6.00% since 04/04/24 | ||
| Low | 7.25 on 06/04/24 | 17.00 on 09/20/24 | 1.98 on 08/12/24 | ||
| High | 11.42 on 07/26/24 | 61.90 on 07/31/24 | 4.27 on 04/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 191,441 | 205,297 | 175,257 | ||
| Shares Outstanding, K | 24,481 | 10,687 | 62,148 | ||
| Annual Sales | 7,200,000 | 0 | 0 | ||
| Annual Net Income | -28,570,000 | -44,600,000 | -41,070,000 | ||
| Last Quarter Sales | 2,230,000 | 0 | 0 | ||
| Last Quarter Net Income | -6,920,000 | -10,000,000 | -12,370,000 | ||
| 60-Month Beta | 0.82 | 2.53 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 08/08/24 | -0.90 on 08/06/24 | -0.20 on 08/13/24 | ||
| Latest Earnings Date | 11/07/24 | 11/05/24 | 11/11/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||